Literature DB >> 11508453

Hepatitis with interface inflammation and IgG, IgM, and IgA anti-double-stranded DNA antibodies following infliximab therapy: comment on the article by Charles et al.

G Saleem, S C Li, B R MacPherson, S M Cooper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11508453     DOI： 10.1002/1529-0131(200108)44:8<1966::AID-ART339>3.0.CO;2-3

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  15 in total

Review 1.  Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety.

Authors:  K L Hyrich; A J Silman; K D Watson; D P M Symmons
Journal:  Ann Rheum Dis       Date:  2004-07-08       Impact factor: 19.103

Review 2.  Autoimmune hepatitis induced by adalimumab with successful switch to abatacept.

Authors:  A Grasland; R Sterpu; S Boussoukaya; I Mahe
Journal:  Eur J Clin Pharmacol       Date:  2011-12-29       Impact factor: 2.953

Review 3.  Hepatotoxicity Associated with the Use of Anti-TNF-α Agents.

Authors:  Joshua B French; Maurizio Bonacini; Marwan Ghabril; David Foureau; Herbert L Bonkovsky
Journal:  Drug Saf       Date:  2016-03       Impact factor: 5.606

4.  Hemophagocytic syndrome occurring in an adult liver transplant recipient having Still's disease.

Authors:  Sanjaya K Satapathy; M Isabel Fiel; Juan Del Rio Martin; Costica Aloman; Thomas D Schiano
Journal:  Hepatol Int       Date:  2010-10-24       Impact factor: 6.047

5.  Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: A single center report of 8 cases.

Authors:  Susana Rodrigues; Susana Lopes; Fernando Magro; Hélder Cardoso; Ana Maria Horta e Vale; Margarida Marques; Eva Mariz; Miguel Bernardes; Joanne Lopes; Fátima Carneiro; Guilherme Macedo
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

Review 6.  Anti-tumour necrosis factor agent and liver injury: literature review, recommendations for management.

Authors:  Roberta Elisa Rossi; Ioanna Parisi; Edward John Despott; Andrew Kenneth Burroughs; James O'Beirne; Dario Conte; Mark Ian Hamilton; Charles Daniel Murray
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

7.  Onset of liver damage after a single administration of infliximab in a patient with refractory ulcerative colitis.

Authors:  Enzo Ierardi; Nicola Della Valle; Maurizio Cosimo Nacchiero; Vincenzo De Francesco; Giuseppe Stoppino; Carmine Panella
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

Review 8.  Liver injury from tumor necrosis factor-α antagonists: analysis of thirty-four cases.

Authors:  Marwan Ghabril; Herbert L Bonkovsky; Clarissa Kum; Tim Davern; Paul H Hayashi; David E Kleiner; Jose Serrano; Jim Rochon; Robert J Fontana; Maurizio Bonacini
Journal:  Clin Gastroenterol Hepatol       Date:  2013-01-17       Impact factor: 11.382

Review 9.  Tumor necrosis factor-α inhibitors and chronic hepatitis C: a comprehensive literature review.

Authors:  Maurizio Pompili; Marco Biolato; Luca Miele; Antonio Grieco
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

10.  Tumour necrosis factor-alpha inhibitor-induced hepatic injury in patients with rheumatoid arthritis: two case reports and an analysis of the laboratory data from the Slovenian national biologicals registry.

Authors:  Katja Perdan-Pirkmajer; Alojzija Hočevar; Žiga Rotar; Janez Žibert; Vera Ferlan Marolt; Filip Gučev; Matija Tomšič
Journal:  Rheumatol Int       Date:  2012-09-07       Impact factor: 2.631
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.